tiprankstipranks

Diane Young Insider Profile

4 Followers
Diane Young, VP, Chief Medical Officer at Oncternal Therapeutics, holds 17.11K shares in Celldex (Ticker: CLDX), holds 45.94K shares in Oncternal Therapeutics (Ticker: ONCT).
tipranks
Diane Young

Diane Young
Oncternal Therapeutics (ONCT)
VP, Chief Medical Officer

Ranked #33,706 out of 99,335 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

+3.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$504K
89.61%
10.39%
A breakdown of Diane Young's holdings

Insider Roles

Celldex
(CLDX)
SVP, CHIEF MEDICAL OFFICER
Oncternal Therapeutics
(ONCT)
VP, Chief Medical Officer
Roles that Diane Young holds in companies

Most Profitable Insider Trade

Stock:
Celldex
(CLDX)
Rating:Informative Buy
Date:Jun 12, 2020 - Jun 12, 2021
Return:+297.90%
The most profitable trade made by Diane Young

Diane Young's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncternal Therapeutics
Jul 17, 2018
VP, Chief Medical Officer
Uninformative Sell
30.05K
$52.37K
Celldex
Jun 13, 2024
SVP, CHIEF MEDICAL OFFICER
Uninformative Buy
40.65K
$451.84K
List of latest transactions for each holding click on a transaction to see Diane Young's performance on stock

Diane Young insider profile FAQ

What is the percentage of profitable transactions made by Diane Young?
The percentage of profitable transactions made by Diane Young is 67%.
    What is the average return per transaction made by Diane Young?
    The average return per transaction made by Diane Young is 3.40%.
      What stocks does Diane Young hold?
      Diane Young holds: ONCT, CLDX stocks.
        What was Diane Young’s latest transaction?
        Diane Young latest transaction was an Uninformative Buy of $40.65K.
          What was Diane Young's most profitable transaction?
          Diane Young’s most profitable transaction was an Informative Buy of CLDX stock on June 12, 2020. The return on the trade was 297.90%.
            What is Diane Young's role in Oncternal Therapeutics?
            Diane Young's role in Oncternal Therapeutics is VP, Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.